Document:

Exhibit 4.2
​
DESCRIPTION OF CAPITAL STOCK
​
As of December 31, 2020, the common stock of Virios Therapeutics, Inc. (the “Company”) is registered under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
​
The following description of our capital stock, certain provisions of our certificate of incorporation and bylaws and certain provisions of Delaware law is a summary and is qualified in its entirety by reference to our certificate of incorporation, bylaws and the Delaware General Corporation Law (the “DGCL”). Copies of our certificate of incorporation and our bylaws have been filed with the SEC and are filed as exhibits to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission of which this Exhibit is a part.
​
General
​
Our authorized capital stock consists of 43,000,000 shares of common stock, par value $0.0001 per share, and 2,000,000 shares of preferred stock, par value $0.0001 per share. As of December 31, 2020, there were 8,305,075 shares of our common stock, held by approximately 205 stockholders of record and no shares of our preferred stock are designated, issued or outstanding.
​
Common Stock
​
Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. An election of directors by our stockholders shall be determined by a plurality of the votes cast by the stockholders entitled to vote in the election. Subject to the supermajority votes for some matters, other matters shall be decided by the affirmative vote of our stockholders having a majority in voting power of the votes cast by the stockholders present or represented and voting on such matter. Holders of common stock are entitled to receive proportionately any dividends as may be declared by our board of directors, subject to any preferential dividend rights of any series of preferred stock that we may designate and issue in the future.
​
In the event of our liquidation or dissolution, the holders of common stock are entitled to receive on a pro rata basis our net assets available for distribution to stockholders after the payment of all debts and other liabilities, subject to the prior rights of any holders of outstanding preferred stock. Holders of common stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future.
​
Preferred Stock
​
Under the terms of our certificate of incorporation our board of directors is authorized to direct us to issue shares of preferred stock in one or more series without stockholder approval. Our board of directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock.
​
The purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third party to acquire, or could discourage a third party from seeking to acquire, a majority of our outstanding voting stock. Upon the closing of this offering, there will be no shares of preferred stock outstanding, and we have no present plans to issue any shares of preferred stock.
​

Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws
​
Some provisions of Delaware law, our certificate of incorporation and our bylaws make the following transactions more difficult: an acquisition of us by means of a tender offer; an acquisition of us by means of a proxy contest or otherwise; or the removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions which provide for payment of a premium over the market price for our shares.
​
These provisions, summarized below, are intended to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of the increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.
​
Authorized but Unissued Shares
​
Our authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital and corporate acquisitions. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of a majority of our common stock by means of a proxy contest, tender offer, merger or otherwise.
​
Stockholder Meetings
​
Any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent.
​
Requirements for Advance Notification of Stockholder Nominations and Proposals
​
Stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder’s notice.
​
Delaware Anti-Takeover Statute
​
We are subject to Section 203 of the General Corporation Law of the State of Delaware, which prohibits persons deemed to be “interested stockholders” from engaging in a “business combination” with a publicly held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an “interested stockholder” is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation’s voting stock. Generally, a “business combination” includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors.
​
Choice of Forum
​
The Court of Chancery of the State of Delaware is the exclusive forum in which we and our directors may be sued by our stockholders, to the fullest extent permitted by law, for:
​
		·
	any derivative action or proceeding brought on our behalf;

​

		·
	any action asserting a breach of fiduciary duty;

​
		·
	any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our certificate of incorporation, or our bylaws; or

​
		·
	any action asserting a claim against us that is governed by the internal affairs doctrine.

​
​
Our bylaws will not apply to suits brought to enforce a duty or liability created by the Securities Act or the Exchange Act, or any other claim for which federal courts have exclusive jurisdiction.
​
These choice of forum provisions may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find either choice of forum provision contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition.
​
Advance Notice Requirements
​
Our bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to the board of directors. Stockholders at an annual meeting will only be able to consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has given our Secretary timely written notice, in proper form, of the stockholder’s intention to bring that business before the meeting. Although our bylaws do not give the board of directors the power to approve or disapprove stockholder nominations of candidates or proposals regarding other business to be conducted at a special or annual meeting, our bylaws may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed or may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of us.
​
Transfer Agent and Registrar
​
The transfer agent and registrar for our common stock is Broadridge Corporate Issuer Solutions, Inc.
​
National Securities Exchange Listing
​
Our common stock is listed on the Nasdaq Capital Market under the symbol “VIRI.”ex_201625.htm

	
			Exhibit 10.1

			 

			Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

			 

			Contract No 840/08625142/31/22-21

			Date 18.03.2021

			
	
			THE SELLER

			Isotope-Regional Alliance, Joint Stock Company(JSC «Isotope»)

			Pogodinskaya str., 22, Moscow, 119435, Russia.Phone: +7(495) 981-96-16.

			
	
			THE BUYER/ THE CONSIGNEE/ THE END USER

			 

			The Company IsoRay Medical Inc.

			350 Hills Street, Suite 106

			Richland, WA 99354-5411 USA

			Contact person: [**]; Michael Hansen, tel: 509.375.1202

			 

			Airport of destination: Seattle, USA.

			Additional airports of destination: Los Angeles, New York, USA.

			together - “the Parties”,

			
	
			NOTIFICATION

			FedEX Trade Networks 16353 NE Cameron Blvd

			Portland, Oregon 97230 USA

			Phone: +1503-255 1391 ext.14

			
	
			THE CONSIGNOR

			- Research Institute of Nuclear Materials, Joint-Stock Company (INM JSC) 

			P.O.Box 29, Zarechny, Sverdlovsk Region, Russia, 624250 Tel.: +7 (343 77) 350 01,

			Fax: 7 (34377) 333 96

			 

			 or -

			 

			Isotope-Regional Alliance, Joint Stock Company (JSC «Isotope»)

			Pogodinskaya str., 22, Moscow, 119435, Russia. Phone: +7(495) 981-96-16

			
	
			TERMS OF DELIVERY

			FCA airport Yekaterinburg or Moscow airport, Russian Federation (Incoterms 2020)

			

 

 

	
			THE MANUFACTURER

			- Research Institute of Nuclear Materials, Joint-Stock Company (INM JSC)

			P.O.Box 29, Zarechny,

			Sverdlovsk Region, Russia, 624250

			Tel.: +7 (343 77) 350 01

			Fax: +7 (343 77) 733 46

			E-mail: rtd@inm-rosatom.ru

			
	
			THE BUYER and THE SELLER have mutually agreed that the Seller with supply the following Goods to the Buyer during the year 2021-2022:

			
	
			 

			Total activity of the shipments on calibration date not more than, Ci

				
			Price, USD/Ci,

				
			Total, USD

			
	
			 

			 

			 

			[**]

			 

			 

				
			 

			 

			 

			[**]

			 

			 

				
			 

			 

			 

			[**]

			 

			 

			
	
			Total Amount of the Contract: [**] 

				 	 	 
	
			The price of the Goods is stated on FCA airport Yekaterinburg or Moscow airport, Russian Federation (Incoterms 2020).

			 

			Quantity and (or) activity of the Goods requirements:

			The above number of Goods and total amount of the contract are to be understood as frame value only, whereas the actual number of the Goods, quality parameters and total amount of the Contract will be based on the Buyer’s written orders, confirmed by the Seller, by means of sending to the Buyer the acceptation of the Buyer’s order.

			 

			The order containing airport of destination must be sent to the Sellers not later than 3 weeks before planning delivery date mentioned in the order.

			 

			Total activity of the lot of goods is established in accordance with the calibration date (Tuesday of the week following the week of delivery) provided in the Buyers written order set to 12:00 p.m. (noon) Pacific Standard Time.

			 

			Each quarter the Buyer shall send to the Seller and the Manufacturer preliminary shipment schedule for production planning purposes.

			

 

 

	
			The Buyer’s representations and warranties:

			Under the present Contract the Goods will be used:

			 

			- for the production of medical sources;

			 

			- only for the purposes stipulated in the present contract specifically excluding any military use, production of nuclear explosive devices or weapons of mass destruction.

			 

			The Goods will not be re-exported and will be used by the end user in the territory of the USA. The Seller is entitled to verify whether the Goods are used in accordance with the purposes stipulated in the present contract. The Buyer undertakes to make all arrangements necessary for such a verification by the representatives of the Seller. 

			 

			The Buyer agrees to protect, defend, indemnify and hold the Seller and its affiliated and subsidiary companies and their respective officers, directors, employees and agent (together, the "Indemnified Parties") harmless from all claims, losses, damages, and expenses that may be asserted against or be incurred by the Indemnified Parties whether direct or indirect, foreseeable or unforeseeable, including, but not limited to, those resulting from injuries to any person or damage to any property, caused in any manner by any act or failure to act of Buyer in connection with this Contract, or based upon any claim of product liability or strict liability in tort.  In the event such indemnity as described above is prohibited by law, then said indemnity shall only be to the extent caused by the Buyer’s negligent acts or omissions to the extent allowed by applicable law.

			 

			
	
			Terms of packaging of the Goods: 

			The Goods are to be shipped in non-returnable type A transport packing sets. The value of the packing sets is included into the Goods price.

			

 

 

	
			Disclosure terms:

			The Buyer  warrants to the Seller that all data and records regarding the Buyer’s entire ownership chain and leadership including beneficiaries (inter alia ultimate beneficiaries)  submitted electronically from the Buyer’s e-mail address to the Seller’s e-mail address  isotop@isotop.ru, (further herein referred to as “Information”) are full, accurate and true.In the event of change in the Buyer’s  Information,  the Buyer shall notify the Seller in writing within 5 (Five) days of such change which notice shall be supported by copies of  relevant records, either notarized or undersigned by the duly authorized signatory.

			 

			In accordance with the applicable laws of the Russian Federation the Buyer  hereby agrees and acknowledges consent of all concerned or affiliated persons to  present  the Information, for the disclosed Information to be processed by the Seller, and for further disclosure of the Information in whole or in part by the Seller to competent authorities including the Federal Tax Service of Russia, Russian Ministry of Energy, Federal Service for Fiscal Monitoring, and Russian Government, and further processing of disclosed Information by such authorities (further herein referred to as Disclosure). The Buyer hereby discharges  the Seller from all liability resulting from such Disclosure and is liable to reimburse to the seller any damages, losses and expenses incurred due to raising any claims raised by any  third party, whose rights were or may be infringed by such Disclosure.

			 

			Both the Buyer and the Seller confirm that the provisions concerning disclosure of the Information and keeping such Information up to date are recognized by the Parties as material terms and conditions of the present Contract.Failure to disclose, late disclosure and (or) incorrect disclosure and (or) incomplete disclosure of Information, including notice of change of Information together with supporting documents, in a timely and accurate manner, in whole or in part, is considered a valid reason to terminate the Contract at the Seller’s sole discretion and make claims against the Buyer  to reimburse damages resulting from such termination. The Contract shall be deemed terminated as of the date of receipt of written notice of the Seller by the  Buyer  unless a later date is specified in such notice.

			 

			While executing the present Contract, the Parties are complying and shall comply with all the applicable laws and regulations, including any anti-bribery and anti-corruption laws.

			 

			The Parties or any of their officials, employees, shareholders, representatives, agents, or any persons acting on behalf or by request of any Party under this Contract, shall not directly or indirectly, under commercial relationships with other businesses or the public sector, offer, give, execute, or agree to offer, give, execute (independently or by agreement with other persons) any payment, gift, or other benefit with the purpose of executing any provisions of the present Contract, if such actions violate any anti-bribery or anti-corruption laws or regulations applicable to the Parties.

			
	The present Contract shall come into effect upon signature and terminates on 31.03.2023.
	
			All other terms and conditions of the Contract are nominated in Appendixes 1 and 2 to the Contract and are an integral part thereof.

			
	The Contract and any Appendixes and Addendа to the Contract shall be considered legally binding if provided by facsimile transmission or by e-mail.

 

 

	THE SELLER	THE BUYER
	/s/ Anton Shargin, Director of Department of Isotope Products Sales	/s/ Jennifer Streeter, COO, Dated: March 11, 2021

 

 

 

 

	
			 

			TERMS OF PAYMENT

			APPENDIX No 1

			to Contract No. 840/08625142/31/22-21

			Date 18.03.2021

			 

			Payment is to be made by the BUYER in USD within 30 (thirty) calendar days from the date of delivery of the goods.

			 

			The payment is to be made by the Buyer to the following Seller’s account:

			 

			Isotope-Regional Alliance, Joint Stock Company «Isotope» (JSC «Isotope»)

			119435, Moscow, Russia, 22 Pogodinskaya str.

			OÀO SBERBANK Moscow, Russia

			121930, Moscow, Zubovskiy bulvar, 13/1

			Account: [**],

			SWIFT: SABRRUMM

			 

			The payment is to be received on the above mentioned account of the Seller not later than in 50 (fifty) calendar days from the date of the delivery of the goods.

			 

			All expenses, fees and commissions of the Buyer's bank are to be paid by the Buyer, all expenses, fees and commissions of other banks shall be paid by the Seller. Thereby, the amount due to the Seller is the amount of payment from Buyer to Seller less fees and commissions of intermediary banks and other banks except commissions of the Buyer's bank. 

			 

			The Buyer's payment obligation is considered fulfilled from the moment when the payment is credited to the above-mentioned Seller’s account.

			

 

 

 

	THE SELLER	THE BUYER
	/s/ Anton Shargin, Director of Department of Isotope Products Sales	/s/ Jennifer Streeter, COO, Dated: March 11, 2021

 

 

 

 

	
			APPENDIX No 2

			to Contract No. 840/08625142/31/22-21

			Date: 18.03.2021

			 

			GENERAL CONDITIONS OF DELIVERY

			 

			1. Terms of delivery 

			1.1. When delivering the goods on terms under FCA Yekaterinburg or Moscow (INCOTERMS 2020) the Consignor shall hand over the goods to the carrier named by the Buyer, or, if such a carrier has not been named by the Buyer, to the Consignor’s Transport Agent. The air freight charged at the place of departure shall be paid by the Buyer by his own.

			1.2. The title as well as all the risks which the goods may be subject to shall be transferred to the Buyer at the [**].

			1.3. The [**]

			1.4. The Goods are delivered with the following documents:

			- Invoice (3 copies);

			- Quality Certificate (2 copies);

			- Shipping specification (2 copies).

			 

			2. Quality of the Goods

			2.1. The quality of the Goods should meet the contractual technical requirements and should be confirmed by the Quality Certificate issued by the producer of the Goods.

			 

			3. Quantity of Goods

			3.1. The quantity of sent goods in specified units should be attested by Packing List drawn up by the Manufacturer of goods.

			 

			4. Terms of Transportation

			4.1. No later than [**] prior to the date of delivery the Buyer is obliged to provide shipping instructions to the Seller/Manufacturer (consignor), advising them on all necessary shipping details. In case the Buyer fails to send any information in due time without which the shipment of goods is impossible, the Buyer bears all additional expenses arising out of this and all the risks which the goods may be exposed to, starting from the agreed date of delivery or after the expiry of the agreed time of delivery.

			4.2. The Consignor is responsible for providing physical protection, security and other measures to ensure physical protection in relation to the delivered goods until the transfer of the Goods in Moscow or Yekaterinburg airport in accordance with the requirements of the legislation of the state through which the goods will be transported.

			4.3. The Consignee assumes responsibility for ensuring physical protection of guards and other measures to ensure physical protection in relation to the delivered goods after the moment of the transfer of the Goods in Moscow or Yekaterinburg airport in accordance with the requirements of the legislation of the state through which the goods will be transported.

			 

			5. Notice of Shipment

			5.1. During one working day after the shipment the Seller shall forward the following data to the Buyer by e-mail or fax:

			 

			- date of shipment;

			- denomination of goods;

			- quantity of goods;

			- Contract number;

			- quality characteristics (Quality Certificate with the stamp of the Manufacturer);

			- flight and Waybill numbers.

			 

			6. Delivery and Acceptance of Goods

			6.1. The goods shall be considered as delivered by the Seller and accepted by the Buyer:

			- in respect of gross weight and number of pieces – according to the waybill (packing list);

			- in respect of net weight and other specified units - according to the Shipping Specification;

			- in respect of quality – according to Quality Certificate.

			 

			7. Claims

			7.1. If on the arrival of goods to the place of destination there is any lack of conformity of their quality to the provisions of the Contract due to circumstances excluding the responsibility of the Carrier or in case of ascertainment of shortage of goods inside the intact original packing of the producer of goods, i.e. when there are no traces of penetration to the cargo during transportation, the Buyer has the right to make claims against the Seller.

			7.2. Given the specific nature of the goods, the Buyer understands and expressly agrees that no Claims may be made later than [**] from the delivery date and that such time period is reasonable and conscionable.

			7.3. Claims in respect of quality and quantity should be accompanied by the Statement drawn up at the place of destination with participation of the Seller’s representative or by the Statement of an official control organization of the Buyer’s country.

			7.4. The Seller is liable for alteration in quality of the goods or for shortage of the goods after risks have passed to the Buyer only in case if they occurred through the fault of the Seller.

			7.5. The liability of the Seller under this Contract (whether for lack of conformity of quality or quantity or otherwise) shall in no event exceed the price of the claimed lot of goods.

			7.6. The Buyer agrees that return of the claimed lot of goods and repayment of the purchase price for such claimed goods shall be the sole remedy available to the Buyer for lack of conformity of quantity or quality, and that the Seller shall not be obliged to deliver substitute goods or to pay compensation for losses or damages incurred by the Buyer.

			7.7. In case of delay in delivery of goods through the Buyer’s fault the Seller doesn’t bear responsibility for change in quality of goods which occurred because of the radioactive decay of isotopes.

			7.8. No claims made for any individual lot of the Goods may be a reason for the Buyer to refuse to accept or pay for other deliveries under the present Contract.

			7.9. Any shipments returned by the Buyer must be preliminary agreed upon with the Seller. If prior agreement has not been obtained the Seller is not liable for compensation for the losses suffered by the Buyer.

			7.10. In case of return of the claimed goods the Buyer is to deliver the goods in packing which ensures safety of goods during transportation.

			 

			8. Penalties

			8.1. In case the Seller does not deliver the Goods in time stipulated in the Contract the Seller is to pay a penalty amounting to [**] for each day of delay but no more than [**] of value of the not delivered goods.

			8.2. In case the Buyer does not make the payment in the time stipulated in the Contract the Buyer is to pay the penalty amounting to [**] for each day of delay but no more than [**] of delivered value.

			8.3. In case the Buyer’s payment is not received in the account of the Seller in the time stipulated in the contract the Seller has the right to demand reimbursement of the expenses related to the payment of the penalties imposed on the Seller under the currency regulation and currency control legislation of Russian Federation.

			8.4. The obligation of the defaulting party to pay a penalty arises upon written demand submitted by the other party. In case of delay in performance the penalty shall accrue from the date of due performance by the party of its obligation hereunder.

			 

			9. Licenses 

			9.1. The Seller is obliged at their risk and expenses to receive the Export License, and the Buyer - the Import License.

			9.2. The Party is obliged to inform the other Party on the obtaining of the License for importation / exportation of Goods under the present Contract, in case of necessity of such License, not later than 30 days prior to the month of delivery.

			 

			10. Force-majeure

			10.1. Neither Party shall bear responsibility for the complete or partial non-performance of any of its obligations (except for failure to pay any sum which has become due under the provisions hereof), if the non-performance results from such circumstances as flood, fire, earthquake and other acts of God as well as war, military operations, blockade, acts or actions of state authorities or any other circumstances beyond the Parties control that have arisen after the conclusion of the contract. In this case the time stipulated for the performance of an obligation under the contract is extended correspondingly for the period of time of action of these circumstances and their consequences.

			10.2. The Party for which the performance of obligation became impossible shall immediately notifies in written form the other Party of the beginning, expected time of duration and cessation of above circumstances. Certificate of a Chamber of Commerce (Commerce and Industry) or other competent authority or organization of the respective country shall be a sufficient proof of commencement and cessation of the above circumstances.

			 

			11. Arbitration

			11.1. Any dispute, controversy or claim arising out of or in connection with this Contract, or the breach, termination or invalidity thereof, shall be finally settled by arbitration in accordance with the Arbitration Rules of the Arbitration Institute of the Stockholm Chamber of Commerce.

			11.2. The arbitral tribunal shall be composed of a sole arbitrator, appointed by the Arbitration Institute of the Stockholm Chamber of Commerce.

			11.3. The place of arbitration shall be Stockholm, Sweden.

			11.4. The language to be used in the arbitral proceedings shall be English.

			11.5. This Contract shall be governed by, and construed in accordance with, the substantive laws of Sweden without reference to its conflict of laws rules. The application of the United Nations Convention on Contracts for the International Sale of Goods is expressly excluded.

			 

			 12. Other conditions

			12.1. All taxes, duties, fees and other expenses whatsoever connected with the fulfillment of the Contract on the territory of the Seller’s country are to be paid by the Seller and beyond it – at the expenses of the Buyer, unless otherwise provided in accordance with the delivery basis agreed upon by the Parties.

			12.2. Neither of the parties is entitled to transfer its rights and obligations under the Contract to any third party without the written consent of the other Party.

			12.3. Any alternations and/or additions to the Contract are valid only if they are made out in written form and signed by the duly authorized representatives of the Parties.

			12.4. The Parties undertake to maintain confidentiality with respect to the information contained in this contract and also concerning information about financial, economic or other activities of a Party that was provided to the other Party or became known in connection with preparation or execution of this Contract. The Parties have the right to transfer information related to this Contract subject to the prior consent of the other Party.

			12.5. Restrictions on disclosure of information, mentioned in item 12.4 of the present Contract, will not apply if such disclosure is (i) made to affiliated companies, professional advisors, or (ii) necessary to comply with the requirements of any applicable legislation.

			12.6. The provisions of this section regarding Confidentiality will remain in force for 3 (three) years after expiration of this Contract.

			12.7. In case of necessity of transfer by one of the Parties to the other Party of information constituting a commercial secret, the Parties undertake to conclude a Non-disclosure Agreement, otherwise such information will not be provided.

			12.8. The Parties acknowledge that the information contained in this contract may be disclosed by one of the Parties without the consent of the other party to the following third parties: organizations that maintain accounting and tax records, auditors, accounting and tax accounting consultants, if necessary to ensure the effective implementation of this contract and provided that such third parties to whom the said information is to be disclosed, are aware of the confidential nature of such information and have assumed a written obligation to comply with the confidentiality restrictions applicable to the information provided to them.

			12.9. All Appendixes mentioned in the Contract are its integral parts.

			12.10. After the signing of the Contract all preceding negotiations and correspondence concerning the Contract are deemed to be null and void.

			12.11. Moscow is considered to be the place of the Contract signing.

			12.12. Facsimile signature or signature by email of the Contract and all Appendixes and Addenda is permissible.

			12.13. The present Contract is signed in two identical copies, one for each Party, each copy is in Russian and English. English text takes precedence over Russian text.

			 

			13. Additional representations and warranties

			Each Party assures another Party on the following:

			- Signing of the Contract by the Party is not in contradiction directly or indirectly with any laws, decrees, other normative acts, acts of public authorities and / or local self-government, local regulatory acts, judicial decisions;

			- The Party has received all necessary permissions and approvals for signing the Contract (inter alia in accordance with current legislation of the Party’s country or the Party’s founding documents, including approval of a transaction with related parties and approval of a material transaction).

			 

			

 

 

 

	THE SELLER	THE BUYER
	/s/ Anton Shargin, Director of Department of Isotope Products Sales	/s/ Jennifer Streeter, COO, Dated: March 11, 2021

 

 

 

 

APPENDIX No 3

to Contract No. 840/08625142/31/22-21

Date: 18.03.2021

 

 

	
			PRODUCT QUALITY REQUEREMENTS

			
	
			1. Physical form.

			1.1. Dried product with solids content of approximately [**] per shipment.

			
	
			2. Chemical form.

			2.1. Any soluble salt of Cesium. There are no requirements for the determination of the specific chemical composition of the Cesium salt.

			
	
			3. Radiochemical purity.

			3.1. Cs isotopes activity ratios per calibration (alert levels):

			Cs-132/Cs-131:< [**];

			Cs-134/Cs-131:< [**];

			Cs-136/Cs-131:< [**];

			Cs-137/Cs-131: < [**];

			3.2. Impurities activity ratios per calibration (alert levels):

			Ba-131/Cs-131: < [**];

			Ba-133/Cs-131: < [**];

			La-140/Cs-131: < [**];

			Co-60/Cs-131: < [**];

			Sb-122/Cs-131: < [**];

			Sb-124/Cs-131: < [**];

			Au-198/Cs-131: < [**];

			Zn-65/Cs-131: < [**];

			Ir-192/Cs-131: < [**];

			Sum of all other gamma emitters: <[**].

			

 

 

	THE SELLER	THE BUYER
	/s/ Anton Shargin, Director of Department of Isotope Products Sales	/s/ Jennifer Streeter, COO, Dated: March 11, 2021

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]